Funder
Novartis Pharmaceuticals Corporation
Publisher
Springer Science and Business Media LLC
Reference87 articles.
1. Kolkhir P, Giménez-Arnau AM, Kulthanan K, Peter J, Metz M, Maurer M. Urticaria. Nat Rev Dis Primers. 2022;8(1):61.
2. Gonçalo M, Giménez-Arnau A, Al-Ahmad M, et al. The global burden of chronic urticaria for the patient and society. Br J Dermatol. 2021;184(2):226–36.
3. Goldstein S, Eftekhari S, Mitchell L, et al. Perspectives on living with chronic spontaneous urticaria: from onset through diagnosis and disease management in the US. Acta Derm Venereol. 2019;99(12):1091–8.
4. Toubi E, Giménez-Arnau AM, Maurer M, Vadasz Z. Articular angioedema in patients with chronic spontaneous urticaria is frequently misdiagnosed as arthritis. J Allergy Clin Immunol Pract. 2020;8(9):3232–3.
5. Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022;77(3):734–66.